WARREN, N.J. WARREN, N.J. Aquestive Therapeutics Inc. on Monday reported a loss of $2 million in its third quarter. The Warren, New Jersey-based company said it had a loss of 3 cents.
Reiterates commencement of pivotal pharmacokinetic (PK) study for Anaphylm™ (epinephrine) Sublingual Film expected in fourth quarter 2023 with topline data.
Aquestive Therapeutics Completes $45 Million Debt Refinancing itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
WARREN, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ:AQST) (the "Company" or "Aquestive"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'